Reader TTS

Access through your institution Buy or subscribe Data supporting continuous long-term testosterone therapy for hypogonadal middle-aged and elderly men have been published in _Clinical

Endocrinology_. Hypogonadal men involved in an ongoing observational study received testosterone at baseline and 6 weeks and then every 12 weeks for a maximum of 11 years. For 147 patients,

therapy was interrupted after a mean duration of 65.5 months, owing to issues with cost reimbursement (140 men) or a diagnosis of prostate cancer (seven men). All patients resumed therapy

after a mean interval of 16.9 months and continued treatment for a mean of 14.5 months. The remaining 115 men involved in the study received continuous testosterone treatment. This is a

preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online access $209.00 per

year only $17.42 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated

during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support REFERENCES * Yassin, A. _ et al_. Effects of

intermission and resumption of long-term testosterone replacement therapy on body weight and metabolic parameters in hypogonadal in middle aged and elderly men. _Clin. Endocrinol. (Oxf.)_

10.1111/cen.12936 Download references Authors * Louise Stone View author publications You can also search for this author inPubMed Google Scholar RIGHTS AND PERMISSIONS Reprints and

permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Stone, L. Continuous testosterone is beneficial. _Nat Rev Urol_ 12, 594 (2015). https://doi.org/10.1038/nrurol.2015.235 Download citation *

Published: 15 September 2015 * Issue Date: November 2015 * DOI: https://doi.org/10.1038/nrurol.2015.235 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this

content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative